GPCR Signaling in Cancer: Advances in Cancer Research, cartea 145
Arun K. Shuklaen Limba Engleză Hardback – 21 feb 2020
G protein-coupled receptors (GPCRs) constitute a large family of cell surface receptors which are involved in nearly every cellular and physiological event. These receptors can recognize a broad array of ligands and they are targeted by nearly one third of the currently prescribed drugs including anti-cancer therapeutics.
- Covers the latest concepts in GPCR signaling and their relevancy to cancer biology
- Presents new indications for anti-cancer therapeutic programs
- Includes sections on cross-talk and signaling networks of GPCRs and effectors in molecular oncology and therapeutics
Din seria Advances in Cancer Research
- Preț: 76.76 lei
- 32% Preț: 683.43 lei
- 33% Preț: 686.52 lei
- 5% Preț: 1167.51 lei
- 32% Preț: 684.11 lei
- 29% Preț: 717.38 lei
- 29% Preț: 716.57 lei
- 29% Preț: 714.27 lei
- 9% Preț: 685.82 lei
- 5% Preț: 715.52 lei
- 5% Preț: 719.20 lei
- 30% Preț: 716.84 lei
- 29% Preț: 719.79 lei
- 30% Preț: 716.77 lei
- 19% Preț: 806.51 lei
- 29% Preț: 721.13 lei
- 36% Preț: 726.10 lei
- 25% Preț: 721.41 lei
- 25% Preț: 720.90 lei
- 20% Preț: 778.01 lei
- 28% Preț: 689.92 lei
- 29% Preț: 687.71 lei
- 26% Preț: 717.69 lei
- 28% Preț: 692.66 lei
- 25% Preț: 719.01 lei
- 25% Preț: 722.41 lei
- 25% Preț: 722.69 lei
- 29% Preț: 686.27 lei
- 29% Preț: 686.27 lei
Preț: 719.17 lei
Preț vechi: 1018.32 lei
-29% Nou
Puncte Express: 1079
Preț estimativ în valută:
137.68€ • 150.07$ • 115.77£
137.68€ • 150.07$ • 115.77£
Carte tipărită la comandă
Livrare economică 11-25 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128202302
ISBN-10: 0128202300
Pagini: 164
Dimensiuni: 152 x 229 x 10 mm
Greutate: 0.4 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Cancer Research
ISBN-10: 0128202300
Pagini: 164
Dimensiuni: 152 x 229 x 10 mm
Greutate: 0.4 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Cancer Research
Public țintă
Primary researchers and clinicians involved in molecular oncology research and cancer therapeuticsCuprins
1. HERs Transregulation in Cancer Progression: From Discovery to 2020 and Beyond Rakesh Kumar 2. RTKs in Cancer Biology Paul Fisher 3. Advances in EGFR Biochemistry and Biology Yosef Yarden 4. Mouse Models of RTKs/HERs: Lessons and Implications to Biology and Therapy William Joseph Muller 5. MET Receptor in Oncology: From Biomarker to Therapeutic Target Ravi Salgia 6. RTKs in Pathobiology of Head & Neck Cancer Radhakrishna Pillai 7. HER2 or Nuclear HER/RTK in Cancer Mien-Chie Hung 8. FLT3 in Hematopietic Malignancies: From Pathobiology to Therapeutics Premkumar Reddy 9. Advances in IGF1R Biology and –directed Cancer Therapeutics Douglas Yee 10. Advances in Bcr-Abl in Cancer Therapy and Biology Nandini Verma 11. EphRs in Cancer Development and Progression Renata Pasqualini 12. RTK-directed Clinical Advances: Trials and Treatments Masakazu Toi